Migraine Meds Recalled for Bacteria Risk
The bacteria, from the genus pseudomonas and the genus burkholderia, can enter the bloodstream and cause serious, life-threatening infections. (Source: WebMD Health)
Source: WebMD Health - August 16, 2019 Category: Consumer Health News Source Type: news
Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
Review located one suitable RCT (n=100) which found that inhaled aztreonam lysine did not improve FEV1 and time to next exacerbation vs placebo. Authors therefore conclude that there is insufficient evidence to determine an effective antibiotic strategy for this infection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 8, 2019 Category: Consumer Health News Source Type: news
Rugby Laboratories Issues Voluntary Nationwide Recall of Diocto Liquid and Diocto Syrup Manufactured By PharmaTech, LLC Due to Possible Product Contamination
Rugby ® Laboratories of Livonia, MI is voluntarily recalling all lots within the expiry of Diocto Liquid and Diocto Syrup, (docusate sodium solutions) manufactured by PharmaTech, LLC of Davie, FL due to a risk of product contamination with Burkholderia cepacia. If a product contains B. cepacia, its use c ould result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. Some of these infections may be serious or even life-threatening in the at-risk patient population. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination
HelloLife, Inc. in Grand Rapids, MI is initiating a voluntary recall of four different products, Neuroveen, Respitrol, Thyroveev and Compulsin, within expiry, to the retail and consumer level due to possible microbial contamination. Neuroveen has been tested and found to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin has been identified as containing Burkholderia cepacia.
Respitrol and Thyroveev are still pending bacterial identification. Each product being recalled is for a single lot that was packaged into 2-ounce amber bottles (see table below) that were manufactured at the King Bi...
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
King Bio Issues Voluntary Nationwide Recall of Aquaflora Candida HP9, Lymph Detox, and Baby Teething Liquids Due to Microbial Contamination
King Bio is voluntarily recalling four lots of Aquaflora Candida HP9, Lymph Detox, and Baby Teething liquids to the consumer level. During a routine inspection by the U.S. Food and Drug Administration, the products were found to contain microbial contaminants Pseudomonas Brenneri, Pseudomonas Fluroescens and Burkholderia Multivorans. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Carbohydrate-dependent B cell activation by fucose-binding bacterial lectins
Bacterial lectins are typically multivalent and bind noncovalently to specific carbohydrates on host tissues to facilitate bacterial adhesion. Here, we analyzed the effects of two fucose-binding lectins, BambL from Burkholderia ambifaria and LecB from Pseudomonas aeruginosa, on specific signaling pathways in B cells. We found that these bacterial lectins induced B cell activation, which, in vitro, was dependent on the cell surface expression of the B cell antigen receptor (BCR) and its co-receptor CD19, as well as on spleen tyrosine kinase (Syk) activity. The resulting release of intracellular Ca2+ was followed by an incre...
Source: Signal Transduction Knowledge Environment - March 4, 2019 Category: Science Authors: Wilhelm, I., Levit-Zerdoun, E., Jakob, J., Villringer, S., Frensch, M., Übelhart, R., Landi, A., Müller, P., Imberty, A., Thuenauer, R., Claudinon, J., Jumaa, H., Reth, M., Eibel, H., Hobeika, E., Römer, W. Tags: STKE Research Articles Source Type: news
Hellolife, Inc. Issues Voluntary Worldwide Recall of Neuroveen, Respitrol, Thyroveev and Compulsin due to Possible Microbial Contamination
HelloLife, Inc. in Grand Rapids, MI is initiating a voluntary recall of four different products, Neuroveen, Respitrol, Thyroveev and Compulsin, within expiry, to the retail and consumer level due to possible microbial contamination. Neuroveen has been tested and found to be contaminated with Staphylococcus saprophyticus and Burkholderia cepacia. Compulsin has been identified as containing Burkholderia cepacia.
Respitrol and Thyroveev are still pending bacterial identification. Each product being recalled is for a single lot that was packaged into 2-ounce amber bottles (see table below) that were manufactured at the King B...
Source: Food and Drug Administration - August 29, 2018 Category: Food Science Source Type: news
King Bio Issues Voluntary Nationwide Recall of Aquaflora Candida HP9, Lymph Detox, and Baby Teething Liquids Due to Microbial Contamination
King Bio is voluntarily recalling four lots of Aquaflora Candida HP9, Lymph Detox, and Baby Teething liquids to the consumer level. During a routine inspection by the U.S. Food and Drug Administration, the products were found to contain microbial contaminants Pseudomonas Brenneri, Pseudomonas Fluroescens and Burkholderia Multivorans. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 20, 2018 Category: Food Science Source Type: news
Products Approved for Other Bioterrorism Emergencies
U.S. Food and Drug Administration. 09/08/2017 This Web page lists products approved for seven bioterrorism emergencies: Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major and Variola minor; Tularemia due to Francisella tularensis; and Zika Virus Disease. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 9, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news
An Eradication Protocol for B. Cepacia Complex in CF An Eradication Protocol for B. Cepacia Complex in CF
The authors describe a protocolized approach that effectively eradicated Burkholderia cepacia complex in cystic fibrosis patients.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 2, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Burkholderia and Yersinia Pestis
North Dakota Department of Health. 06/23/2017 This course discusses the history of Yersinia pestis, and the methods of transmission of Burkholderia. It describes the various symptoms and stages of disease of Yersinia and Burkholderia, lists treatment options for disease caused by Yersinia and Burkholderia, and compares and contrasts laboratory identification methods of Yersinia pestis and Burkholderia. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - December 8, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news
Mid Valley Pharmaceutical LLC Issues Voluntary Recall of Doctor Manzanilla Cough & Cold and Doctor Manzanilla Allergy & Decongestant Relief Syrup Due to Potential Contamination with Burkholderia Cepacia.
Mid Valley Pharmaceutical is recalling lot# 23221701 of Doctor Manzanilla Cough& Cold and lot# 23221701 of Doctor Manzanilla Allergy& Decongestant Relief syrup to the consumer level. The products may potentially be contaminated with the bacteria Burkholderia cepacia. Contaminated products with Burkholderia cepacia can potentially result in serious infections, may be life-threating in patients with compromised immune systems. To date, Mid Valley Pharmaceutical, LLC has not received any reports of adverse events related to this recall. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 30, 2017 Category: Food Science Source Type: news
MassDevice.com +5 | The top 5 medtech stories for August 23, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Microinnovation: what paper towels have to teach us about medtech
How can you double the efficiency of a paper towel? Turns out you don’t need to reformulate or make the paper thicker. Instead, you find a simple concept that ...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Centurion Labs Issues Voluntary Nationwide Recall of Ninjacof (Lot # 200N1601) and Ninjacof A (Lot# 201NA1601) Products Due to Potential < em > Burkholderia Cepacia < /em > Contamination
Centurion Labs is voluntarily recalling, as a precautionary measure, 1 lot of Ninjacof (Lot# 200N1601) and 1 lot of Ninjacof A (Lot# 201NA1601) manufactured by Vilvet (Dania Beach, FL) and distributed by Centurion Labs to the retail level due to potential contamination with Burkholderia cepacia. Centurion was notified by the FDA regarding the potential contamination as they discovered this product may have been manufactured in a Pharmatech, FDA registered facility, in Davie, FL. that was found to have a product that contained B. cepacia. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 23, 2017 Category: Food Science Source Type: news
Stryker slips on Sage Products recall
Stryker (NYSE:SYK) shares slipped today after the medical device company said it’s recalling some of the products sold by subsidiary Sage Products and narrowed its outlook for the rest of the year.
Kalamazoo, Mich.-based Stryker paid $2.7 billion in April 2016 for Sage and its line of products designed to prevent so-called “never events.” But it wasn’t long before problems emerged with some of those products; by August Sage had expanded an existing recall of impregnated cloth topical skin products over contamination issues with the bacteria Burkholderia cepacia. That recall covered the Comfort Shie...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Hospital Care Recalls Regulatory/Compliance Sage Products Stryker Source Type: news
